Sr VP Global Clinical Dev
Roy Baynes is Senior Vice President and Head, Global Clinical Development and Chief Medical Officer at Merck Research Laboratories in Rahway, New Jersey. He was previously Senior Vice President of Oncology, Inflammation and Respiratory Therapeutics at Gilead Sciences and prior to that, was Vice President, Global Clinical Development and Therapeutic Area (TA) Head for Hematology/Oncology, at Amgen Inc. In the early years of his tenure at Amgen, he was TA Head for Hematology/Oncology in Global Medical Affairs. He graduated as a Medical Doctor and obtained a Masters of Medicine and Doctor of Philosophy from the University of the Witwatersrand, Johannesburg, South Africa. He has had a long and distinguished career in the haematology-oncology and stem cell transplantation fields, including drug development, basic research, clinical practice, clinical research, teaching, and administration. He is a member of many international societies, including the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO), and has authored in some 150 publications. He has been recurrently named among America’s top physicians. Before joining Amgen in 2002, he was the Charles Martin Professor of Cancer Research at the Barbara Ann Karmanos Cancer Institute, an NCI-designated Comprehensive Cancer Center, at Wayne State University in Detroit, Michigan.